MRI diagnosis of NF-1 in children without cafe-au-lait skin lesions

Pediatric Neurology

Volumn 18, Issue 3, 1998, Pages 269-271

  Curless, Richard G ^a   Siatkowski, Michael ^a   Glaser, Joel S ^a   Shatz, Norman J ^a  

^a Dept Neurol Div Pediat N   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CAFE AU LAIT SPOT; CHILD; CLINICAL ARTICLE; HUMAN; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE GLIOMA; PRIORITY JOURNAL;

ADOLESCENT; CAFE-AU-LAIT SPOTS; CHILD; CHILD, PRESCHOOL; HUMANS; INCIDENCE; MAGNETIC RESONANCE IMAGING; NEUROFIBROMATOSIS 1; OPTIC NERVE NEOPLASMS;

EID: 0031890253     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(97)00189-6     Document Type: Article

References (17)

1. Goldstein SM, Curless RG, Post JD, Quencer RM. A new sign of neurofibromatosis on magnetic resonance imaging of children. Arch Neurol. 46:1989;1222-1224.
2. NIH consensus development conference. Neurofibromatosis conference statement. Arch Neurol 1988;45:575-8.
3. Cohen ME, Duffner PK. Tumors of the brain and spinal cord including leukemic involvement. Swaiman KF. Pediatric neurology: Principles and practice. 2nd ed. 1994;900-902 CV Mosby, St. Louis, MO.
4. Lund AM, Skovby F. Optic gliomas in children with neurofibromatosis type 1. Eur J Pediatr. 150:1991;835-838.
5. Brown EW, Riccardi VM, Mawad M, Handel S, Goldman A, Bryan RN. MR imaging of optic pathways in patients with neurofibromatosis. AJNR. 8:1987;1031-1036.
6. Bognam JR, Edwards MK, Lee JA, Dunn DW, Roos KL, Klatte EC. Cranial MR imaging in neurofibromatosis. AJNR. 9:1988;461-468.
7. Duffner PK, Cohen ME, Seidel G, Shucard DW. The significance of MRI abnormalities in children with neurofibromatosis. Neurology. 39:1989;373-378.
8. Joy P, Roberts C, North K, de Silva M. Neuropsychological function and MRI abnormalities in neurofibromatosis type 1. Dev Med Child Neurol. 37:1995;906-914.
9. DiMario FJ, Ramsby G, Greenstein R, Langshur S, Dunham B. Neurofibromatosis type 1 Magnetic resonance imaging findings . J Child Neurol. 8:1993;32-39.
10. Menor F, Marti-Bonmati L. CT detection of basal ganglion lesions in neurofibromatosis type 1 Correlation with MRI . Neuroradiology. 34:1992;305-307.
11. Sevick RJ, Barkovich AJ, Edwards MS, Koch T, Berg B, Lempert T. Evolution of white matter lesions in neurofibromatosis type 1 MR findings . AJR. 159:1992;171-175.
12. Sainio M, Strachan T, Blonstedt G, et al. Presymptomatic DNA and MRI diagnosis of neurofibromatosis 2 with mild clinical course in an extended pedigree. Neurology. 45:1995;1314-1322.
13. Lazaro C, Gaxona A, Ravella A, Volpiny V, Estivill X. Prenatal diagnosis of neurofibromatosis type 1 From flanking RFLPS to intragenic microsatellite markers . Prenat Diagn. 15:1995;129-134.
14. Riccardi VM. Neurofibromatosis Phenotype, natural history, and pathogenesis . 2nd ed. 1992;42-47 The Johns Hopkins University Press, Baltimore.
15. Gomez MR. Neurocutaneous diseases. Bradley WG, Daroff RB, Fenichel GM, Marsden CD. Neurology in clinical practice. 2nd ed. 1996;1562-1566 Butterworths-Heinemann, Boston.
16. Riccardi VM. Neurofibromatosis Phenotype, natural history, and pathogenesis . 2nd ed. 1992;280-316 The Johns Hopkins University Press, Baltimore.
17. North K, Joy P, Yuille D, et al. Specific learning disability in children with neurofibromatosis type I Significance of MRI abnormalities . Neurology. 44:1994;878-883.